Sino Biopharmaceutical Li...

OTC: SBMFF · Real-Time Price · USD
0.99
0.00 (0.10%)
At close: Aug 13, 2025, 12:40 PM
0.99
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Sino Biopharmaceutical Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
6.99B 5.93B 5.78B 18.57B
Depreciation & Amortization
n/a 1.07B 1.05B 992.56M
Stock-Based Compensation
53.72M 18.12M 29.72M n/a
Other Working Capital
n/a 250.19M 195.51M -281.66M
Other Non-Cash Items
-1.85B -529.74M -394.56M -13.86B
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
n/a -430.51M -195.59M -339.13M
Operating Cash Flow
n/a 6.07B 6.27B 5.37B
Capital Expenditures
n/a -1.7B -1.71B -1.89B
Cash Acquisitions
n/a -742.71M -58.52M -958.7M
Purchase of Investments
n/a -1.65B -4.48B -4.85B
Sales Maturities Of Investments
n/a 2.56B 1.08B 903.24M
Other Investing Acitivies
n/a 142.09M 1.1B 4.28B
Investing Cash Flow
n/a -756.98M -4.07B -2.52B
Debt Repayment
n/a -1.75B 1.05B -1.64B
Common Stock Repurchased
n/a -396.39M -867.61M -332.93M
Dividend Paid
n/a -632.67M -1.27B -938.49M
Other Financial Acitivies
n/a -3.77B -2.1B -316.24M
Financial Cash Flow
n/a -6.55B -3.19B -3.23B
Net Cash Flow
-1.27B -1.15B -944.73M -1.02B
Free Cash Flow
n/a 4.36B 4.56B 3.47B